Showing results (2071-2080 of 2,492) with videos related to

Sort By:
Pageof 250
Der Nervenarzt|May 12, 2012
[S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations]A Pfennig, T Bschor, T Baghai, et al.
Molecular Phylogenetics and Evolution|April 28, 2016
Molecular phylogeny of Panaspis and Afroablepharus skinks (Squamata: Scincidae) in the savannas of sub-Saharan AfricaMaria F Medina, Aaron M Bauer, William R Branch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 17, 2019
A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizabilityRosie E Curiel Cid, David A Loewenstein, Monica Rosselli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Journal of Substance Abuse Treatment|June 17, 2021
Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managersAndrew H Talal, Urmo Jaanimägi, Kathleen Davis, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Clec12a tempers inflammation while restricting expansion of a colitogenic commensalTyson R Chiaro, Kaylyn M Bauer, Kyla S Ost, et al.
The Journal of Bone and Joint Surgery. American Volume|February 14, 2025
Delayed-Onset Neurologic Changes Following Posterior Spinal Fusion: A Case SeriesNicholas D Fletcher, Hilary Harris, Jorge Fabregas, et al.
Environmental Microbiology|August 13, 2004
The genome of Desulfotalea psychrophila, a sulfate-reducing bacterium from permanently cold Arctic sedimentsR Rabus, A Ruepp, T Frickey, et al.
Investigational New Drugs|April 14, 2021
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumorsGerald S Falchook, Marc Peeters, Sylvie Rottey, et al.
Hepatology (Baltimore, Md.)|May 16, 2023
Etiological cure prevents further decompensation and mortality in patients with cirrhosis with ascites as the single first decompensating eventMarta Tonon, Lorenz Balcar, Georg Semmler, et al.
Pageof 250